InfuSystem (NYSE:INFU) Director Buys $44,400.00 in Stock

InfuSystem Holdings, Inc. (NYSE:INFU) Director Paul Andrew Gendron acquired 5,000 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The stock was purchased at an average cost of $8.88 per share, with a total value of $44,400.00. Following the purchase, the director directly owned 70,000 shares in the company, valued at approximately $621,600. This trade represents a 7.69% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.

InfuSystem Trading Up 4.9%

InfuSystem stock opened at $8.61 on Friday. The company has a 50 day moving average price of $9.63 and a 200 day moving average price of $9.18. InfuSystem Holdings, Inc. has a 52 week low of $5.08 and a 52 week high of $11.04. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The firm has a market capitalization of $173.77 million, a price-to-earnings ratio of 143.52 and a beta of 1.49.

Wall Street Analyst Weigh In

Separately, Roth Mkm reaffirmed a “buy” rating and issued a $15.00 price objective (up from $14.00) on shares of InfuSystem in a research note on Tuesday, February 24th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $15.00.

Institutional Investors Weigh In On InfuSystem

A number of institutional investors have recently modified their holdings of the stock. Sei Investments Co. boosted its stake in shares of InfuSystem by 123.8% during the 1st quarter. Sei Investments Co. now owns 104,757 shares of the company’s stock valued at $967,000 after buying an additional 57,948 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of InfuSystem by 6.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 594,288 shares of the company’s stock valued at $5,486,000 after buying an additional 33,410 shares during the period. Heartland Advisors Inc. boosted its stake in shares of InfuSystem by 2.0% during the 1st quarter. Heartland Advisors Inc. now owns 510,000 shares of the company’s stock valued at $4,707,000 after buying an additional 10,000 shares during the period. Hillsdale Investment Management Inc. boosted its stake in shares of InfuSystem by 1.1% during the 1st quarter. Hillsdale Investment Management Inc. now owns 452,373 shares of the company’s stock valued at $4,175,000 after buying an additional 5,000 shares during the period. Finally, Hsbc Holdings PLC raised its holdings in shares of InfuSystem by 5.7% during the 1st quarter. Hsbc Holdings PLC now owns 30,097 shares of the company’s stock valued at $281,000 after purchasing an additional 1,619 shares in the last quarter. Institutional investors and hedge funds own 71.13% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.